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Abstract
Background: There is little research regarding the ability of Black men who have sex with men and women
(BMSMW) to access and maintain HIV-related health care and treatment adherence. This population, who often
insist on secrecy about their same-sex desire, may experience unique barriers to seeking regular care and treatment.
Methods: From March 2011-April 2014, we recruited 396 BMSMW in the San Francisco Bay Area to be enrolled in
our randomized controlled trial. At baseline we administered a behavioral survey assessing: demographics,
homelessness, employment, history of incarceration, HIV status and disclosure practices, care and treatment
adherence. 64 men reported living with HIV at intake. To learn more about their experiences, we recruited N = 25 to
participate in qualitative interviews, which were conducted April-December 2014. Topics included: current living
situation, diagnosis story, disclosure practices, experiences of accessing and maintaining care and treatment, and
HIV-related stigma. Recordings were transcribed and coded for major themes.
Results: Despite being located in an area where treatment is plentiful, men faced social and economic barriers to
maintaining regular care and treatment adherence. Several findings emerged to shed light on this quandary: (1)
Competing needs particularly around attaining stable housing, food security, and money created barriers to
treatment and care; (2) Side effects of HIV medications discouraged men from adhering to treatment; (3) Provider
and Institutional level characteristics influenced care engagement; (4) Disclosure and social support made a
difference in care and treatment behaviors; and (5) Participants expressed a desire for group-based intervention
activities to support treatment and care among HIV+ BMSMW. Inadequate engagement in the continuum of care
for HIV was born out in the quantitative data where 28% of participants did not know their Viral Load.
Conclusions: A holistic approach to HIV health for BMSMW would appear to translate to better outcomes for men
living with HIV, where a goal of viral suppression must also include attending to their basic social and economic
support needs.
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Background
Antiretroviral therapy (ART) has been shown to not
only benefit those living with HIV but to dramatically
reduce the likelihood of onward HIV transmission once
individuals are virally suppressed [1]. Thus, “treatment
as prevention” has been promoted as a core pillar of
the National HIV/AIDS Strategy [2]. Yet, only a quarter
of people living with HIV in the United States (US)
have achieved the treatment goal of HIV viral suppres-
sion [3]. Indeed, there are significant gaps and health
disparities along the HIV continuum of care, from HIV
testing, to linkage and engagement in care, and to ad-
hering to medication regimens. HIV continues to dis-
proportionately impact Black Americans in the US, and
Black men who have sex with men (BMSM) continue
to experience the brunt of new cases annually and to
experience higher rates of morbidity and mortality due
to HIV/AIDS [4–6]. Recent studies have found that
Black individuals enter care later in the course of the
disease, are less likely to initiate care and ART, and are
less likely to adhere to ART in comparison to White in-
dividuals [7, 8]. In the San Francisco Bay Area, Black
men in both San Francisco and Alameda counties are
linked at rates that are lower than men of other ethnici-
ties, and they remain engaged in care, and achieve viral
suppression, at lower rates when compared to White,
Latino and Asian Pacific Islander men [9, 10]. For ex-
ample, among new male HIV cases in San Francisco in
2013, 60% of Black men were virally suppressed, com-
pared to 74% of Latino men, 69% of Asian Pacific Is-
lander men, and 64% of White men. Black men
experience disparities in HIV-related outcomes all
along the care continuum [10]. Given the continued in-
crease in cases of HIV infection among Black Ameri-
cans, and BMSM in particular, it is urgent that
prevention scientists develop interventions that in-
crease regular engagement in care, access to ART, and
use of support services that encourage adherence in
this population [11].
Among BMSM, Black men who have sex with both
men and women (BMSMW) have received little atten-
tion regarding their HIV care and treatment needs.
BMSMW have complex sexual lives, with studies de-
scribing behavioral risk factors in this population that in-
clude multiple partners, inconsistent condom use,
substance use in conjunction with unprotected anal and
vaginal intercourse, and non-disclosure of their same-
sex behaviors due to a need for secrecy and privacy [12–
15]. Recent data indicate that BMSMW who are living
with HIV are diagnosed later than other MSM, are more
likely to be poor, and are more likely to experience bar-
riers to accessing regular health care [16]. BMSMW are
also less likely to be well informed about HIV, and are
more likely to have concurrent sex partners [17].
A nascent literature on MSMW who are living with
HIV has described their sexual risk behaviors, disclosure
practices, substance use, and levels of depression as be-
ing different than those experienced by men who have
sex with men only and men who have sex with women
only [18]. MSMW living with HIV have been found to
have higher Viral Loads than MSM, for example [19].
However, the literature examining engagement in HIV
care and treatment among MSMW, and particularly
among BMSMW, is sparse. BMSMW who do not iden-
tify as gay may not feel welcome in clinical settings
catering to gay-identified men, and Black men in par-
ticular express distrust of the medical system [20], which
has implications for tracking and encouraging positive
clinical outcomes and medication adherence. In an era
where “test-and-treat” represents the primary avenue to-
wards controlling and reducing new HIV infections
among BMSM especially, little is known about how
BMSMW who are living with HIV navigate issues re-
lated to accessing and maintaining HIV treatment and
care. Furthermore, it is not clear how BMSMW view
viral suppression and their own ability to seek and main-
tain treatment over their lifetimes.
To develop an understanding of these issues, we em-
bedded a qualitative study of BMSMW living with HIV
into a larger HIV prevention trial called the “Bruthas
Project”. This trial aimed to test a counseling intervention
to reduce sexual risk behavior and increase regular HIV
testing among those who were HIV-negative [21]. Not-
ably, the Bruthas Project did not include any intervention
activities to explicitly address the HIV-related health needs
of HIV-positive men, and so the specific issues related to
HIV-positive status were unaddressed in the design of the
study. We sought to augment our understanding of the
treatment and care experiences of HIV-positive BMSMW
in our sample using qualitative in-depth interviews, with
the overarching goal of informing subsequent intervention
research focusing on the unique needs of this group.
Methods
A full description of the Bruthas Project has been pub-
lished previously [22]. Briefly, the intervention involved
four individual counseling sessions with a Black male
counselor in which participants discussed their sexual
risk behaviors with female and male partners and exam-
ined the social and situational factors that influenced
sexual decision making. Participants completed assess-
ments at baseline and at 6- and 9-months post-
enrollment to evaluate the intervention compared with a
single-session control, and planned exit interviews fol-
lowing the 9-month assessment sought to examine par-
ticipants’ experiences in the intervention program.
Of the N = 396 men originally recruited for a random-
ized controlled trial of Bruthas, 16% (N = 64) were living
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with HIV. From April-December 2015, we conducted
in-depth interviews with N = 25 HIV-positive men who
completed the Bruthas Project trial to examine their ex-
periences as a man living with HIV and to elicit their
ideas for a more tailored intervention to meet their
unique needs. Participants were purposively selected
based on their assignment to the intervention or control
condition (with half of our sample recruited from each
arm), self reported viral load (half self-reported being
virally suppressed), and willingness to return for an add-
itional interview. Baseline quantitative data from our
participants were used to purposively select individuals
to invite to participate in the qualitative interviews. In-
terviews were conducted by two Black male research as-
sociates (JW and WS), who were also the primary field
staff for the Bruthas trial. Interviewers were trained in
qualitative interviewing techniques and followed a semi-
structured interview guide. Interviewers took field notes
and wrote up interview summaries immediately follow-
ing data collection, which the research team used to de-
velop our analysis. The interview guide was initially
piloted with three participants, then revised for specific
wording and ordering of topics. Interview topics in-
cluded: current living situation, diagnosis story, current
access and use of HIV-related services and care, social
support for living with HIV, their doctor-patient rela-
tionship, other health conditions, and suggestions for
treatment and care interventions for HIV+ BMSMW.
Participants received $35.00 at the end of their inter-
view. Interviews were recorded and professionally tran-
scribed. The Institutional Review Board at the University
of California San Francisco reviewed and approved the
study protocol. The study also complies with the
COREQ guidelines and checklist for designing and dis-
seminating the results of a qualitative study [23].
The research team (EA, JW, MB, WS) read through all
interview transcripts and met weekly to discuss emer-
gent themes and potential intervention implications
based on the data, using principles from the Framework
Analysis Method [24]. By including interviewers (JW
and WS) as well as community-based service providers
(MB) in this process, we were able to incorporate key
field-based insights into our analytical framework. Fol-
lowing each meeting, the lead author (EA) wrote analytic
memos summarizing the transcripts and group discus-
sions to further develop theory and depth of understand-
ing about the data. A codebook was developed that
captured the primary themes and sub-themes, defining
the themes within analytic codes, which were then ap-
plied to transcripts. The lead author (EA) and another
research team member (JW) separately coded a total of 5
interviews to establish coder agreement, meeting weekly
to discuss coding and resolve discrepancies in coding.
Once 90% coder agreement threshold was achieved, the
research team members (EA, WS and JW) coded the
remaining transcripts using Dedoose, a cloud-based ana-
lytic program. Once the data were coded, the team
searched Dedoose using particular codes, compiled rele-
vant quotes and met again to discuss the results and to
compare findings across the data set. The most relevant
themes, in light of larger goals to achieve viral sup-




The sample for the analyses presented here (N = 25) had
a mean age of 50 (range 38 to 63), and the median time
since diagnosis was 17 years 6 months (range 4 months
to 27 years 9 months). Approximately half of the sample
had received the Bruthas Project intervention (N = 12),
and half had been enrolled in the control condition (N =
13). Quantitative baseline data indicated serious social
and economic vulnerabilities within this sample: 17%
were homeless in the past year, 84% experienced lifetime
incarceration, and 83% were unemployed. In terms of
lifetime incarceration and current levels of unemploy-
ment, the sub-sample reflected trends discerned in the
larger cohort of Bruthas participants, however fewer re-
ported being homeless in the past year than in the larger
cohort (40%). In terms of clinical outcomes, 48% re-
ported having a CD4 count between 500 and 1500, while
20% did not know their CD4 count. Almost half (48%)
reported undetectable Viral Loads, while 28% did not
know their Viral Load. These were comparable to re-
ports in the larger sample of positive participants in the
larger cohort.
Five key findings emerged from our qualitative data to
shed light on the treatment and care experiences of our
study sample: We discuss each key thematic finding in
detail below.
Competing needs and scarcity of affordable housing
Overall, we found that survival needs outweighed clinical
care and adherence issues as the fundamental priority for
participants. Many of our participants experienced sub-
stantial challenges to securing stable housing and suffi-
cient food, and economic realities left quite a few needing
to “hustle” or find work in the informal economy, through
one time informal jobs or scams, in order to augment
their income. In addition, even those receiving public fi-
nancial support through Supplemental Security Income
(SSI), Social Security Disability Insurance (SSDI), or
General Assistance spent a great deal of time seeking out
subsidized housing and food resources. Although partici-
pants were eligible for subsidized housing due to their
HIV status, this resource was considered out of reach due
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to wait lists that could take months or even years to
overcome.
Every place I applied for housing that is 30% of your
Social Security they all have waiting lists. And I think
they should have more buildings you know. Because
rent is high. And some people can’t afford it you
know. First and last deposit and they used to have
places a long time ago that would help you but now
they don’t. (Participant 004, 40–49 years old)
Multiple participants explained they missed medical
appointments to participate in the informal economy or
deal with unstable housing, and therefore they were out
of care and not on treatment. Here one participant de-
scribes skipping care and treatment to attend to more
immediate needs.
Hustle, trying to get a buck or two you know. If
somebody have to go to the doctor’s appointment
but you over here you want to make 20 dollars.
Now if you don’t make that 20 dollars you don’t
have nothing, you’ll go to the doctor and you’ll be
hungry when you meet a doctor. And the doctor
ain’t gonna give you 20 dollars but you know
you’re gonna need it right now. So you gotta do
something to put some money in your pocket.
(Participant 015, 40–49 years old)
Another explains that his Social Security payments can
barely cover rent in San Francisco and that he must sup-
plement his income in order to “get through.” “I’m on
Social Security right now. $845 a month….[but] my rent
is $725 every month…I recycle…And I cut grass, do yard
work, you know that’s the only way I can get through”
(Participant 003, 60–63 years old). Generally, many of
our participants did odd jobs, or collected cans to re-
cycle, in order to make ends meet. Occasionally, a job
would come up that would conflict with a doctor ap-
pointment, and participants prioritized dealing with their
more immediate economic needs over their long-term
health care.
Unstable housing and periods of living on the streets
also contributed to episodes of missing treatment. For
example, a homeless participant developed resistance to
treatment after failing two regimens. He was diagnosed
during a time when he lacked stable housing, and the
chaos of his life made it difficult to remain adherent.
Here he discusses losing his bag (with his medications
inside) and also not wanting to take medication in front
of others at the shelter because of HIV-related stigma.
Back then I was taking, oh goodness, it’s the blue pill.
It was the two combination. Oh goodness, Sustiva –
and it was Sustiva and another one. It was a two pill
combination. So when I came here they just kept me
on that for a while. Then eventually I stopped taking
it and I built a resistance. Then I was on Truvada,
Reyataz and Norvir recently. And I was on it just too
long…and I stopped because I wasn’t consistent. I was
homeless. I had no place to stay. I didn’t know
anybody you know…It’s important to have some type
of stability if you’re going to take these medications…
For the simple reason and fact that if you’re transient
anything could happen. You can lose your bag, you
can lose your medication. (Participant 013, 50–
59 years old)
The material and economic circumstances, and espe-
cially the housing stability, of our participants impacted
their ability to remain connected to care, regularly see
their providers, and adhere to treatment regimens. SSI
and SSDI payments, when received, were not enough to
allow participants to pay rent in one of the most expen-
sive urban centers in the US, and therefore they had to
supplement their income with food from food banks and
odd jobs, interfering with their ability to keep medical
appointments. In extreme instances, participants lost
their housing altogether and experienced quite concrete
challenges to maintaining care and treatment if they
were forced to live on the streets.
Side effects and breaks in treatment
A number of participants had stopped taking their HIV
treatment medications because of side effects or interac-
tions with other medications. A few participants were
not in care or on treatment because they “felt fine” and
believed that medications would make them sick. Here
one participant explains his distrust for pharmaceutical
companies and resistance to treatment. Indeed, misinfor-
mation about medical regimens was part of the social
context in which men were trying to adhere to treat-
ment, making them distrust the impact of the drugs
themselves. For example, this participant claimed the
drugs made him sick:
I just didn’t think it was cool, man. I – it’s like, hell
no. I mean it’s like, I’m healthy. I didn’t feel like I
needed to [take treatment]. Then, come to find out I
sent for this book ‘Everything You Thought You Knew
About AIDS But Didn’t,’ man. I didn’t even know that
the medication they was giving out was cancer
treatment. The pharmaceutical companies, man were
getting over like a fat cat in a pig farm. And so, you
know what I’m saying, it was like, wow. Wow! So it
was like – so I was really, really, hell, no I’m not
taking no medication. And for a while, man my T
cells, you know what I’m saying, just stayed the way
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that they were. They were cool…Viral Load didn’t even –
the body didn’t even know what aViral Load was. You
know? It seems as if I did start taking this damned
medication, man, that’s when all the stuff [changed]. Wow!
Q: You think there’s a connection when you started
taking the meds this happened?
A: Yes, yes, yes, man! Yes! (Participant 012, 50–
59 years old)
A number of older participants had a family history of
diabetes and heart disease, and consequently were deal-
ing with multiple chronic diseases alongside HIV. In sev-
eral cases, this required men to take a variety of
medications, some of which produced unsettling side ef-
fects including fatigue and depression, as described here:
A: Well, along with the HIV now I’m something like
in the stage II diabetes thing to where it’s not out of
control but they want to control it. But hey, man, I’m
taking all these other medications for all this HIV and
my heart disease and those side effects come in. So
now I deal with them but it’s keeping my blood
pressure down. I watch what I eat and everything else.
Q: What kind of side effects are you having?
A: Just like say sometimes I get fatigued real fast.
Like during the day sometimes I might just be
overwhelmed. And it’s even now when I stand up
I get dizzy that I know that’s the diabetes thing.
And then my vision is kind of going off now.
Q: And you also mentioned like that you’re reluctant
to take some medications because you’re taking so
many others already?
A: Yeah. I stopped taking – I cut everybody off for like
2 months, earlier this year. Yeah, doctors, and HIV
meds. I got tired of taking them, man. And they just
were, I’d just go pick them up and pop them in and I
said, man. I just stopped taking them. I stopped taking
everything…But you know I got into a depression state
too. And every time I would open my cabinet I would
see all these bottles. (Participant 018, 50–59 years old)
Here another participant talks about why he didn’t
trust taking the medications prescribed to him by his
doctor. And after he started his regimen, he believes
adverse things started happening with his health.
Q: What kind of side effects would you get?
A: Nauseated, you know? Feeling sick, feeling lazy,
don’t want to do nothing, you know? Feeling
miserable. So I couldn’t take anything that would
make me flip out. It started making me feel bad. I
could feel bad already! You know? So why take a
bunch of pills? I don’t even know nothing about the
pills, really, to tell the truth. I was just doing what the
doctors… what another man said.
Q: So they didn’t explain to you what the pills were?
A: Well they said, sometimes… you know, it’s kind of
hard for me to believe the doctors sometimes.
Because, in this day and age, and I’m not saying he’s a
bad person, but see, when I went on dialysis, you
know… I wasn’t having no pain or nothing. And I
figured that he had me messed up for nothing, you
know? He kept telling me to go to dialysis, calling my
house, “You gotta go to dialysis. Your kidneys are
bad.” Now the kidney is not giving me no problem so
why should I go? And I’m thinking about all that
stuff. I say, man, that messed my life up right there.
I’m thinking about it. Because, a lot of times, I might
not know as much as them. But a lot of times - I’ll be
right. (Participant 015, 40–49 years old)
This participant clearly explains how ‘miserable’ he
started feeling as a result of being on his medications. He
also thought his HIV medications may have contributed
to his kidneys failing and having to start on dialysis. Ini-
tially, he adhered to his regimen mainly because he was
following his doctor’s orders. Eventually he stopped taking
them because he believed they were worsening his health.
This participant lives on SSI payments ($845/month),
which he qualified for based on his HIV-related disability.
At the time of the interview, he was insured through
Medicaid (a publicly-funded form of health insurance)
and had recently changed doctors. Below, he describes the
impact of taking 27 pills a day (the regimen that his
previous doctor had prescribed for him) on his physical
and mental health. He complained that taking that many
pills had a significant negative impact on his ability to
function throughout the day, including his ability to work.
A: I couldn’t function [taking so many pills]. I couldn’t –
I was always asleep. I couldn’t function or do nothing.
Q: Did you ever talk about these issues with your
doctor who was giving you the 27 pills?
A: Yes.
Q: And what was his response to that?
A: He said in time it would get better. And that was
it. And so, because even people who wasn’t a doctor,
they was telling me, “You’re taking too many pills!”
(Laughs) Even my therapist told me, “You’re taking
too many pills. And you need to change doctors.”
So I said, “Okay.” (Participant 004, 40–49 years old)
This participant faithfully adhered to the regimen pre-
scribed by his doctor even though taking 27 pills a day
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had a significantly negative impact on his health and
general ability to function. Eventually, he was empow-
ered by those around him to change doctors. Once he
did that, he claimed that his regimen was immediately
reduced.
Relation to care: provider-level and institutional
characteristics
We found that there were characteristics of providers
and medical institutions that were associated with
whether or not BMSMW were engaged in care and on
treatment.
Provider characteristics and relation to care
Participants who were retained in care and adherent to
their treatment regimens attributed their health behav-
iors to a strong relationship with their doctor, which was
characterized by open communication and trust.
[My doctor] is a foreign woman. I don’t know where
she’s from, but… she’s really nice and personal.
Because I had kinda, like, been slipping on my pills.
Cuz I had been undetectable for a while, you know.
And then I went there and then I wasn’t undetectable
anymore. And she was like, “You’re not taking your
pills! I know that’s what it…” And she got on me, you
know! She really cared, you know? And I really I loved
that…And it made me start taking my pills. Because,
I was saying, you know, I don’t want to go back
and she’d be like, “You promised me all this," and
I didn’t want to disappoint her over myself.
(Participant 020, 50–59 years old)
The same participant had switched from a large public
hospital to this smaller clinic because he felt that the
staff “really cared” about him and would call him if he
missed appointments repeatedly.
If they ain’t seen me in a while they’ll call me and you
know see what’s going on, you know, pretty much just
show someone that they care, you know, that they
really care about whether they’re doing their job, you
know. That’s why I left [a large public hospital] because
[they] never checked on me. And if they hadn’t seen me
in a while or call me and say it’s time for your flu shot
or it’s time for your, you know your Hep shot and all
this. But you know [the new clinic staff] care, that’s why
I go there cuz they care. And they make me feel like
they care so that’s all that matters. That’s all that
matters to me. (Participant 020, 50–59 years old)
Another participant receives care at a large university
hospital and credits the relationship he has with his doc-
tor, who is an African American man, with enabling him
to stay in care and on treatment. Here he describes their
rapport, based on shared cultural understandings and
traditions.
[The clinic is for] all Black men. And they treat us
accordingly, I guess you know. I guess we’re different
from everybody [else]…I ain’t never had a doctor like
him. Never…Yeah, well… now I’m not prejudiced or
nothing, but I feel like if you never walked in a Black
man’s shoes, you don’t know what we go through. So,
he’s an African-American doctor, so I can’t fool him.
He’ll be like, “Man, please!” Do you know what I
mean? Yeah, I can’t tell him nothing. But if I have a
White doctor or a Mexican doctor, something like
that? They care but they don’t care, do you know what
I mean? You’re just a patient there… you’re a patient.
My doctor? We’re personal. We’re real like that, yeah.
(Participant 021, 30–39 years old)
This participant underscores the importance of having
medical providers who reflect the ethnic and racial com-
position of the patients that they care for.
Institutional characteristics and relations to care
In contrast to the participant above, another participant
was not on treatment at the time of the interview. He
was having a challenging time identifying a doctor he
could trust; because of this distrust, he felt unsure about
initiating treatment. His providers were part of a large
Health Maintenance Organization (HMO), which he felt
was “indifferent” to him. Here he describes his search
for an appropriate doctor:
Q: How do you like [Large HMO]?
A: I’m indifferent to [Large HMO]. They’re indifferent
to me and I’m indifferent to them. It’s a struggle, you
know? To want to do things my way and they want to
do it their way. And there’s no meeting in the middle,
unless there is a crisis.
Q: What is their way? When you say ‘their way’?
A: Well, they have rules and regulations. They don’t
go outside the box. It’s [their] way or no way, you
know? But, you know, I don’t necessarily want to go
that route. I want more community involvement,
more groups, you know? For things not to be so rigid!
With [large HMO], everything’s very rigid. And I’ve
struggled… I’m struggling to find that right doctor.
And they think I’m doctor shopping. But I’m not! I’m
just trying to find the right doctor. I’m not taking any
medications. So, therefore, how can I be doctor
shopping? So, I don’t want to start taking medications
with someone I don’t trust, you know? (Participant
019, 40–49 years old)
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Some individuals also experienced differences in care
with expansion of Medicaid and a shrinking network of
providers who were willing to see them, resulting in long
wait times at clinics and very brief and impersonal visits
with their doctors. Here a participant on Medicaid found
that the wait times at his provider’s clinic were as long
as 2–3 h. Here he describes cancelling appointments
due to the wait time:
The only problem I have with it is waiting…But, I
think a lot of these clinics, when you don’t have -
-when you didn’t have, like, [Medicaid] like I have
now, you had to wait. Because if you were getting,
like, [the county-run health insurance plan] or what-
ever, there were only certain places you could go and
use that. So, I know I have to be there 2 or 3 h some-
times. And I hate going. So, sometimes I don’t feel
like it and I cancel the appointment. Like I did the last
two appointments I’ve had. (Participant 007, 40–
49 years old)
Finally, one more participant stayed with the same
doctor and clinic for 10 years while his care team
searched for a way to help him control his HIV. This
participant has been living with HIV for over 20 years
and is connected to a number of services, including
housing and a peer-led group for HIV-positive Black
men. Here he explains that he stayed connected to this
particular clinic because the providers facilitated his ac-
cess to clinical research studies, which enabled him to
be part of trials that tested different regimens. Eventu-
ally, he was placed on his tenth treatment regimen,
which finally worked.
Yeah. And at first they… well, my T-cells? It was like
100. Or 150. We done tried everything… I’ve been in
every medical study, you know, to try to find out. And
the last one I was in, we found the regimen that works
for me. And that’s what they tell me, you know, I usu-
ally tell everybody, “I’ll be the guinea pig. I’ll be the
guinea pig.” And now you know they found a regimen
that works for me so my T-cells went up, my Viral
Load is undetected. And I haven’t had no real health
problems in the last, what, 10 years? (Participant 009,
50–59 years old)
Having a good relationship with one’s doctor and feel-
ing like the clinic could be trusted was a key in allowing
men to stay connected to care and in treatment.
Disclosure and social support for living with HIV
Although some participants had disclosed their HIV
status to friends, family, or sexual partners, roughly a
third were more secretive about their status and
therefore were receiving little to no social support for
remaining in care. Although a few men had widely dis-
closed and therefore had extraordinary levels of social
support from friends, family and formal support groups
for living well with HIV, others were coping with their
HIV alone and in relative isolation. These men felt it was
hard to disclose to family and friends, due to anticipated
HIV-related stigma and fear of rejection. Also some did
not disclose until they were catastrophically ill and in the
hospital. However, for the few who were able to disclose
and elicit support from family or friends, the help they
were able to access impacted their well-being and ability
to stay on treatment and in care.
Q: How much support do you have now?
A: Um, my family and my extended family, nieces and
nephews, great niece and nephew, you know, they all
know. And they’re very supportive, you know. I talk to
them, you know, maybe twice, maybe three times a
week and they always ask me, you know, “How you
doing with your HIV? Are you taking your meds?”
You know. “Are you doing okay?” That’s just the way
they are now. (Laughs) So, that makes me feel… I
mean, I feel, you know, that made me feel good. I felt
good about that. In comparison to, you know, almost
20 years ago, it’s like… (Chuckles)
Q: And as far as outside the family, what other kind
of support do you have?
A: I attend a support group… people dealing with
HIV. It just keeps me – it keeps me grounded. It
makes me… even though I’m doing really well, but
you know, I still have to acknowledge the fact that I’m
still dealing with this. And I need to be aware of that.
It just makes me – it makes me stronger. (Participant
016, 50–59 years old)
Another participant had a female friend who was also
HIV-positive and helps him navigate services, including
successfully applying for SSDI. This participant also had
excellent family support:
Then I was just in a drug whirlwind for like –For
like 4 years after that. And then…my friend came
into my life and, you know, I got sick…I knew her
for a while. I didn’t know she was HIV though.
She was HIV before me. And then when my
parents passed, she was there for me. And then
that’s when …I found out she was also HIV. And
so I was able to talk. I had somebody to talk to.
That was a blessing, man! Thank God for her, boy!
I can tell her about my gay side of life and she was
just heaven sent to me, man. But… and then, you
know, I kinda got sick and in, like, 2005 or’06 or
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something…She’s the one helped me get on [Social
Security Disability Insurance] too! Yeah, and then
of course the first time they turn you down, and I
was ready to give up. And she told me, “No!” – I
remember that – “No! Don’t give up.” You know?
“They’re going to make you fight for it.” And I got
it, you know….Oh, it’s lovely, man!…I don’t have
no problem with food, you know? Because… I go
to my brother’s house and cook. Because I ain’t got
no kitchen. I ain’t got no stove or nothing. And all
I got is a microwave, man! So, I go to my brother’s
every weekend and cook. And then my grandma,
you know a grandmother… She’s always hooking
me up with stuff….So, I got a good home at home,
you know? A foundation. And my whole family
knows about me. And they support me and, you
know… it’s good. (Participant 020, 50–59 years old)
In contrast to the participant above, another partici-
pant was extremely isolated and unable to tell anyone
about living with HIV. He feared disclosing “his busi-
ness” and having his HIV status become known by asso-
ciates also living in the neighborhood where he resided.
After deciding that he could no longer “sneak” to take
his medications, and “giving up," he became so ill that
he was checked into hospice:
Well, you see, I wasn’t taking my medicine. And
stuff like that and my T-cells were gone. And I
mean, I was just giving up, you know? So, then I
went there [to hospice] and came back….I just got
tired of, you know, every time I’m with some-
body… man, I gotta take my medication. I gotta
tell them what I gotta do. And then I gotta sneak
and take it, you know? I just don’t want to tell
nobody my business right now. (Participant 015,
40–49 years old)
This individual explains that he did not want others
knowing about his health situation, and so he stopped
taking his medications. Eventually his health deteriorated
to the point where he had no T-cells left and he was
admitted to a hospice program where he reinitiated
treatment.
These social dynamics demonstrate the impact that
disclosure and social support for living with HIV can
have for participants. In cases where men were able to
disclose their HIV status, especially to others who were
also living with HIV, they were able to get support for
staying on treatment, for being in care, and for being
connected to social resources designed to help those
with HIV. Participants without such strong support did
not do as well, and some came close to dying due to
adherence-related issues.
Group-level and peer support activities
The majority of our participants expressed a desire to join
a support group made up of other BMSMW so they could
discuss matters related to living with HIV, being
BMSMW, and remaining engaged in care and treatment.
This finding emerged in response to questions about the
best format for an intervention, and was surprising due to
the emphasis on the need for privacy and confidentiality
for BMSMW in our earlier intervention development
work. As described, the Bruthas Project was designed as
an individual level, counseling-based behavioral risk re-
duction intervention, but men who were living with HIV
urged the study team to consider adding an additional
small group component for the purposes of providing in-
formational and emotional social support to BMSMW liv-
ing with HIV. For example, one participant was diagnosed
late and his doctor informed him during the initial diagno-
sis that if he had waited another month he would have de-
veloped full blown AIDS and likely died. Consequently,
this participant was depressed and felt that treatment was
futile. Eventually, he joined a support group with other
Black men, where he felt “hope.”
Because at one point, I said, “Hey, I don’t even want
[treatment]… forget it, man! It’s done! It’s over!” You
know? But now, I finally just went on and started
taking the cocktail. I started feeling good about
myself. And just listening to other people’s stories
about how they dealt with it and how they went
through that transition. And then seeing how healthy
they was and stuff like that, that gave me a sense of
hope. (Participant 005, 40–49 years old)
Several men noted that it would be helpful to talk to a
group of people who “had the same problems” and who
were also struggling to take treatment regularly and con-
tinue seeing their medical providers. This participant
notes that the space used for a support group would
need to make everyone feel welcome, not be conspicu-
ous as a place people living with HIV go to, and
convenient.
You know there should be some programs, some
good programs out there for people that’s really
embarrassed and actually don’t want to be seen in
them [HIV-identified] places. That’s one reason why
I left [Hospital X] because there’s too many people
coming in there. People be looking at you, talking
about folks and Lord, you know I don’t care but I
don’t want my business out on the street. (Participant
020, 50–59 years old)
Participants expressed a desire for group sessions with
other BMSMW that centered on information sharing,
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but that also had a component related to social support
and empathy for “having the same problems.” Import-
antly, Participant 020 clearly states that he does not want
to “be seen in them places” which are more HIV-
specific. Furthermore, he does not want others sharing
“his business” with others in the community. The need
to maintain confidentiality about one’s HIV status was
important for many in our cohort, who were reluctant
to be seen in HIV-identified spaces.
Discussion
In this qualitative examination of the treatment- and
care-related needs of BMSMW living with HIV, we
found that participants are prioritizing their basic, more
immediate needs, such as food security and housing,
ahead of maintaining their provider appointments and
medications. Indeed, we observed problems accessing
and limitations in Social Security and other benefits for
this socioeconomically disadvantaged sample, which
undermine their ability to focus on their health. In the
San Francisco Bay Area, as in other global urban centers,
housing costs have skyrocketed in the past several years
and affordable housing is increasingly scarce [25], even
for the middle class, which poses structural challenges in
an environment known for having progressive policies
toward HIV care and treatment. Thus, a purely biomedi-
calized approach to disrupting the HIV epidemic, such
as treatment as prevention, may find limited success in
the absence of programmatic attention to the social con-
ditions that enable healthcare utilization and facilitate
medication adherence. Taking a tailored, individualized
approach towards helping men themselves identify and
successfully garner resources that will allow them to
meet their basic survival needs is one strategy to em-
power and enable a socioeconomically disadvantaged
population, such as the sample for this study, to remain
in care and on treatment.
In addition to economic factors, HIV service and med-
ical professionals must also be aware of co-occurring
health conditions such as substance use and mental
health issues which can create challenges in attaining
stability as well as continuing on treatment. Funding
policies and programs, such as those offered through the
Ryan White Care Act, are essential to provide socio-
economically disadvantaged people living with HIV, such
as those in our sample, access to wrap-around services,
including social workers and case managers, as well as
integrated models of care, where mental health and
substance use treatment can be accessed in the same
location as HIV specialty care [26, 27].
Our participants also experienced a number of severe
health conditions owing to interactions between their
chronic disease medications and their ART. We found
this especially problematic among older segments of the
study sample who are managing aging and chronic dis-
ease along with HIV-specific concerns such as treatment
regimens and side effects. Whereas other investigators
have examined co-morbidities of HIV and aging among
African American women [28], little research has been
conducted with African American men. Among women,
HIV and co-morbidity self-management have been found
to be linked, and those who are more socially isolated
reported less optimal adherence and management [29].
Other studies have reported that patients with co-
morbidities delay ART initiation [30]. Participants in this
sample reflected that, as our population living with HIV
is aging, group-based programs may help to educate
Black MSMW living with HIV about various types of
HIV treatments and side effects, how these might inter-
act with other medications for chronic diseases, and cre-
ate opportunities for support. Groups could potentially
provide space for individuals to rehearse provider com-
munication in order to empower them to request
changes in their medications when needed. Such HIV
support groups for BMSMW could also be held in set-
tings away from hospitals and locales that people with
HIV access, in order to avoid inadvertent disclosure of
participant HIV statuses.
Many of our participants who were in treatment and
regularly seeing a provider reported having a positive re-
lationship with their doctor and social support for living
with HIV. Positive provider relationships, which include
the ability to be open and trusting with one’s provider,
and peer support have been associated with better treat-
ment adherence in qualitative studies with African
American women [31]. However, African American men
in particular have experienced negative encounters with
medical professionals [20]. For our participants, as in
other studies, having providers who were culturally com-
petent with BMSMW, and who often were African
Americans themselves, allowed a deeper level of trust
and honesty to develop. Improving cultural competency
within the provider workforce, and increasing the diver-
sity of the workforce and the number of medical
providers who are African American themselves, may
help BMSMW living with HIV to overcome barriers to
remaining in care and on treatment as they feel more
comfortable forging relationships with their providers.
More research on targeting programs that increase
diversity among healthcare professionals may lend crucial
insights into meeting this unmet need for BMSMW.
Finally, we also observed the important role of social
support for those living with HIV. Participants who were
able to share their health status with family or with
friends expressed a more positive outlook on their
capacity to navigate HIV treatment and care and social
service systems. With disclosure comes the ability to
access social support, which came in the form of food
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assistance, assistance with keeping medical appoint-
ments, and assistance navigating social services designed
to support those with HIV. Investigators have observed
similar patterns among heterosexually-identified African
American men living with HIV, in which social support
and positive coping were associated with better physical
and global functioning [32]. All of the men in this
sample endorsed the idea of support groups for
BMSMW living with HIV, which may offer new direc-
tions for future interventions.
Limitations
This was a purposive sample of men living with HIV
who were enrolled in a randomized controlled trial of
an intervention designed for BMSMW. Participants
interviewed in this study had completed at least one
session of counseling for HIV risk reduction, and thus
may have had greater comfort discussing their experi-
ences living with HIV compared with peers without
this opportunity. It is also likely that the perspectives
of men enrolled in an HIV prevention intervention
trial are different than BMSMW in the general popu-
lation. In addition, the study was conducted in a geo-
graphic region known for having assertive health
policies related to HIV care and treatment, as well as
toward sexual and gender minority populations. How-
ever, it is likely that if our participants were experien-
cing barriers to accessing care and treatment in San
Francisco, one of the best possible social and health-
care settings for BMSMW living with HIV, they will
experience barriers elsewhere. We believe that the
findings may suggest important barriers and facilita-
tors to accessing care and remaining on treatment for
BMSMW who are living with HIV, however due to
the relatively small size of this qualitative study, the
findings cannot be generalized to the larger popula-
tion of BMSMW.
Conclusions
No interventions for addressing the treatment- and
care-related needs or other health co-morbidities exist
for HIV-positive BMSMW. The Bruthas Project is an
individual-level intervention focusing on behavioral
risk reduction for preventing HIV transmission, and
did not contain activities that were directly designed
to support men living with HIV. Although initial find-
ings from the Bruthas trial suggest some promise,
HIV-positive MSMW who participated in the trial
indicated that they experienced structural barriers to
remaining in care and on treatment due to poverty
and unstable housing, and several reported discon-
tinuing their HIV treatment medications due to inter-
actions with medications for other co-morbidities.
These emergent findings suggest the need to design
tailored intervention strategies for HIV-positive BMSMW,
which may include group-level activities to increase social
support for them, and to improve their treatment literacy.
Intervention development for this population must
address the socioeconomic context that might challenge
engagement in clinical care and medical adherence,
support BMSMW to establish and maintain positive
relationships with medical providers, and provide social
support for living with HIV.
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